Funding for this research was provided by:
Agency for Toxic Substances and Disease Registry (U01 GH000731-02)
Fogarty International Center (D43TW009574.)
Received: 24 July 2019
Accepted: 15 April 2020
First Online: 24 May 2020
Ethics approval and consent to participate
: This study was reviewed by three ethics committees/ institutional review boards (IRBs): The Johns Hopkins University School of Medicine IRB and Lakshya IRB as well as the CDC Center for Global Health, Human Subjects Protection Office. A written consent was obtained from all participants.
: Not applicable.
: Under a licensing agreement between emocha Mobile Health, Inc. and the Johns Hopkins University, R. Bollinger is entitled to royalties on an invention described in this article. R. Bollinger also is a Board of Directors member of emocha Mobile Health, Inc. This arrangement has been reviewed and approved by the Johns Hopkins University per its conflict of interest policies.